Abstract
Background Findings from Mendelian randomization (MR) studies are conventionally interpreted as lifelong effects, which typically do not provide insight into the molecular mechanisms underlying the effect of an exposure on an outcome. In this study, we apply two recently developed MR approaches (known as ‘lifecourse’ and ‘tissue-partitioned’ MR) to investigate lifestage specific effects and tissues of action in the relationship between adiposity and circulating leptin levels.
Method Genetic instruments for childhood and adult adiposity were used to estimate lifestage specific effects on leptin levels measured during early life (mean age:10 years) in the Avon Longitudinal Study of Parents and Children (ALSPAC) and in adulthood (mean age:55 years) using summary-level data from the deCODE Health study. This was followed by partitioning body mass index (BMI) instruments into those whose effects are putatively mediated by gene expression in either subcutaneous adipose or brain tissues, followed by using MR to simultaneously estimate their separate effects on childhood and adult leptin levels.
Results There was strong evidence that childhood adiposity has a direct effect on leptin levels at age 10 years in the lifecourse (Beta=1.10, 95% CI=0.90 to 1.30, P=6×10−28), whereas evidence of an indirect effect was found on adulthood leptin along the causal pathway involving adulthood body size (Beta=0.74, 95% CI=0.62 to 0.86, P=1×10−33). Tissue-partitioned MR analyses provided evidence to suggest that BMI exerts its effect on leptin levels during both childhood and adulthood via brain-tissue mediated pathways (Beta=0.79, 95% CI=0.22 to 1.36, P=6×10−3 & Beta=0.51, 95% CI=0.32 to 0.69, P=1×10−7 respectively).
Conclusions Our findings demonstrate the use of lifecourse MR to disentangle direct and indirect effects of early life exposures on time-varying complex outcomes. Furthermore, by integrating tissue-specific data, we highlight the aetiological importance of appetite regulation in the effect of adiposity on leptin levels, as well as raising implications for the gene-environment equivalence assumption in MR.
Funding This work was supported by the Integrative Epidemiology Unit which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/1).
Competing Interest Statement
TGR is an employee of GlaxoSmithKline outside of this work.
Funding Statement
This work was supported by the Integrative Epidemiology Unit which receives funding from the UK Medical Research Council and the University of Bristol (MC_UU_00011/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All individual level data analysed in this study can be accessed via an approved application to ALSPAC (http://www.bristol.ac.uk/alspac/researchers/access/). Summary-level data on adulthood leptin levels were provided by the deCODE Health study which can be found at (https://www.decode.com/summarydata/).
